Financhill
Back

Embecta Vs. Perspective Therapeutics Industry Stock Comparison

Buy
57

EMBC
Embecta

Last Price:
13.58
Seasonality Move:
13.89%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.12
Seasonality Move:
11.55%
Buy
57
Embecta (EMBC) is a Buy

Is Embecta a Buy, Sell or Hold?

  • The current Embecta [EMBC] share price is $13.70. The Score for EMBC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • EMBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EMBC Stock Price Chart

What is Embecta's stock price today?

  • The Embecta share price today is $13.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EMBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

EMBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 46.04 Sell
Chaikin Money Flow: 141397 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.21 - 15.55) Sell
Bollinger Bands (100): (12.55 - 15.33) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 47.65 Sell
Chaikin Money Flow: 430326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.29 - 13.93) Sell
Bollinger Bands (100): (11.4 - 14.56) Buy

EMBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.2 Buy
20-day SMA: 13.97 Sell
50-day SMA: 14.62 Sell
200-day SMA: 14.01 Sell
8-day EMA: 13.38 Buy
20-day EMA: 13.85 Sell
50-day EMA: 14.24 Sell
200-day EMA: 14.83 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.9 Buy
20-day SMA: 12.86 Buy
50-day SMA: 13.78 Sell
200-day SMA: 12.19 Buy
8-day EMA: 12.84 Buy
20-day EMA: 13.09 Sell
50-day EMA: 13.36 Sell
200-day EMA: 11.73 Buy

Embecta Earnings Growth & EMBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.12 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.

Embecta Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):